Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease. - Aye WWT; Stark MR; Horne KL; Livingston L; Grenfell S; Myall DJ; Pitcher TL; Almuqbel MM; Keenan RJ; Meissner WG; Dalrymple-Alford JC; Anderson TJ; et al. (Alzheimer's & dementia (Amsterdam, Netherlands), 2024)